PATARROYO MANUEL E has a total of 18 patent applications. Its first patent ever was published in 1987. It filed its patents most often in United States, Israel and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ANTEX BIOLOG INC, SCHWEIZ ROTES KREUZ and BURNIE JAMES P.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Israel | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Denmark | 1 | |
#7 | New Zealand | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies | |
#4 | Unspecified technologies | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Patarroyo Manuel E | 15 |
#2 | Manuel E Patarroyo | 1 |
Publication | Filing date | Title |
---|---|---|
US5254459A | Nucleotide and amino acid sequences of protein MTP40 of M. tuberculosis and synthetic peptides derived therefrom | |
US5169940A | Nucleotide sequences of protein MTP40 of M. tuberculosis | |
IL100475D0 | Anti-malarial peptides,their copolymers and vaccines comprising them | |
US5171839A | Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom | |
US4957738A | Protein copolymer malaria vaccine | |
US4735799A | Malaria vaccine |